Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 4.88 EUR Market Closed
Market Cap: 55.8m EUR

Relative Value

There is not enough data to reliably calculate the relative value of SHE.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SHE Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
28
vs Industry
72
Median 3Y
0.9
Median 5Y
0.9
Industry
2.6
Forward
0.9
vs History
36
vs Industry
39
Median 3Y
8.9
Median 5Y
9.1
Industry
21.4
Forward
8.7
vs History
30
vs Industry
5
Median 3Y
5.9
Median 5Y
5.9
Industry
16.4
vs History
1
vs Industry
17
Median 3Y
12.1
Median 5Y
6
Industry
22.8
vs History
39
vs Industry
49
Median 3Y
1.5
Median 5Y
1.5
Industry
2.2
vs History
20
vs Industry
75
Median 3Y
0.8
Median 5Y
0.8
Industry
2.9
Forward
0.8
vs History
23
vs Industry
78
Median 3Y
1.4
Median 5Y
1.4
Industry
5.5
vs History
25
vs Industry
48
Median 3Y
3.9
Median 5Y
3.9
Industry
13
Forward
3.8
vs History
23
vs Industry
45
Median 3Y
5.6
Median 5Y
5.6
Industry
16.5
Forward
5.5
vs History
30
vs Industry
5
Median 3Y
5.4
Median 5Y
5.4
Industry
15.6
vs History
11
vs Industry
22
Median 3Y
7.1
Median 5Y
5.1
Industry
18.7
vs History
33
vs Industry
47
Median 3Y
1.3
Median 5Y
1.3
Industry
1.9

Multiples Across Competitors

SHE Competitors Multiples
Shedir Pharma Srl Unipersonale Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IT
Shedir Pharma Srl Unipersonale
MIL:SHE
55.4m EUR 0.9 9.1 4 5.7
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.5 37.2 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.9B USD 5.4 19.9 16.2 21.1
CH
Roche Holding AG
SIX:ROG
261.4B CHF 4.2 27.7 11.8 13.8
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.9 30.2 108.4 158.6
CH
Novartis AG
SIX:NOVN
210.3B CHF 4.7 18.4 11.7 15.1
US
Merck & Co Inc
NYSE:MRK
264.8B USD 4.1 13.9 9.9 11.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.6 14.1 9.9 11.5
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
IT
Shedir Pharma Srl Unipersonale
MIL:SHE
Average P/E: 22.6
9.1
9%
1
US
Eli Lilly and Co
NYSE:LLY
55.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.2
37%
0.8
CH
Novartis AG
SIX:NOVN
18.4
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.9
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14.1
3%
4.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IT
Shedir Pharma Srl Unipersonale
MIL:SHE
Average EV/EBITDA: 400.1
4
7%
0.6
US
Eli Lilly and Co
NYSE:LLY
37.2
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.8
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
11.7
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.9
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.9
1%
9.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IT
Shedir Pharma Srl Unipersonale
MIL:SHE
Average EV/EBIT: 1 712.6
5.7
8%
0.7
US
Eli Lilly and Co
NYSE:LLY
39.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.8
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.6
23%
6.9
CH
Novartis AG
SIX:NOVN
15.1
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.7
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
11.5
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5